NEW YORK (GenomeWeb) – Ambry Genetics announced today that it will partner with Invicro to provide customized genomics and imaging services for the biotechnology and pharmaceutical industry, with a specialized focus on oncology and neurodegenerative diseases.

The partnership will combine Invicro's imaging services and software with Ambry's genomics services to expedite new drug discovery and development.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.